We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
+2.26%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
10 Year Est. Return
AUM
$205M
AUM Growth
-$553K
Cap. Flow
-$3.14M
Cap. Flow %
-1.53%
Top 10 Hldgs %
50.04%
Holding
36
New
3
Increased
14
Reduced
9
Closed
2

Sector Composition

1 Technology 24.11%
2 Healthcare 22.46%
3 Industrials 12.58%
4 Consumer Discretionary 10.76%
5 Financials 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.98T
$15.4M 7.51%
110,728
-15,015
-12% -$2.06M
AAPL icon
2
Apple
AAPL
$4.89T
$14.1M 6.87%
251,692
+36
+0% +$1.88K
GLD icon
3
SPDR Gold Trust
GLD
$130B
$11.5M 5.62%
82,960
RUSHA icon
4
Rush Enterprises Class A
RUSHA
$6.19B
$9.64M 4.7%
562,273
MCK icon
5
McKesson
MCK
$98.5B
$9.64M 4.7%
70,538
+1,110
+2% +$157K
MCHP icon
6
Microchip Technology
MCHP
$44.4B
$8.84M 4.31%
190,238
+20
+0% +$907
BFH icon
7
Bread Financial
BFH
$3.97B
$8.79M 4.29%
86,006
+21
+0% +$2.37K
GILD icon
8
Gilead Sciences
GILD
$169B
$8.4M 4.1%
132,609
+58
+0% +$3.79K
MTH icon
9
Meritage Homes
MTH
$5.17B
$8.29M 4.04%
235,530
+122
+0.1% +$3.81K
CCJ icon
10
Cameco
CCJ
$38B
$8.03M 3.91%
844,996
+100
+0% +$939
BRK.B icon
11
Berkshire Hathaway Class B
BRK.B
$1.06T
$7.56M 3.68%
+36,322
New +$7.48M
LMT icon
12
Lockheed Martin
LMT
$118B
$7.37M 3.59%
+18,888
New +$7.1M
AMLP icon
13
Alerian MLP ETF
AMLP
$12.7B
$7.14M 3.48%
156,320
+87
+0.1% +$4.12K
CELG
14
DELISTED
Celgene Corp
CELG
$7.02M 3.42%
70,655
+34
+0% +$3.23K
NLY icon
15
Annaly Capital Management
NLY
$17.2B
$6.68M 3.26%
189,684
+138,219
+269% +$4.98M
DAL icon
16
Delta Air Lines
DAL
$57B
$6.58M 3.21%
114,330
CE icon
17
Celanese
CE
$5.02B
$6.02M 2.94%
49,263
-15
-0% -$1.69K
AYI icon
18
Acuity Brands
AYI
$10.2B
$5.79M 2.82%
42,970
+10
+0% +$1.3K
AVGO icon
19
Broadcom
AVGO
$1.78T
$5.57M 2.72%
201,730
-64,880
-24% -$1.84M
CTSH icon
20
Cognizant
CTSH
$21.1B
$5.56M 2.71%
92,225
+62
+0.1% +$3.92K
JAZZ icon
21
Jazz Pharmaceuticals
JAZZ
$15.2B
$4.64M 2.26%
36,242
+39
+0.1% +$5.23K
CI icon
22
Cigna
CI
$75.1B
$4.63M 2.26%
30,522
CVS icon
23
CVS Health
CVS
$136B
$4.42M 2.15%
+70,035
New +$4.15M
AZO icon
24
AutoZone
AZO
$50B
$4.15M 2.02%
3,829
-6,727
-64% -$7.54M
BIIB icon
25
Biogen
BIIB
$30.8B
$4.14M 2.02%
17,774
-6
-0% -$1.4K

Similar funds

Muhlenkamp & Co's Q3 2019 Portfolio in Review

As of Q3 2019, Muhlenkamp & Co held 36 positions worth $205M, down 0.27% from $206M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Muhlenkamp & Co's Q3 2019 filing shows 3 new, 14 increased, 9 reduced and 2 closed positions. Its largest new stake was Berkshire Hathaway Class B: 36,322 shares worth $7.56M. The largest sale was Federated Hermes, an estimated $8.03M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Muhlenkamp & Co's largest Q3 2019 buy was Berkshire Hathaway Class B: 36,322 shares worth $7.56M.
  • Muhlenkamp & Co added most to Annaly Capital Management in Q3 2019, an estimated $4.98M increase.
  • Muhlenkamp & Co's biggest Q3 2019 reduction was AutoZone, cutting an estimated $7.54M.
  • Muhlenkamp & Co fully exited Federated Hermes in Q3 2019, selling an estimated $8.03M.
  • Muhlenkamp & Co's ten largest holdings make up 50% of its $205M portfolio in Q3 2019.
  • Muhlenkamp & Co opened 3 new positions and closed 2 in Q3 2019.
  • Muhlenkamp & Co's portfolio value fell 0.27% quarter-over-quarter to $205M.

Based on Muhlenkamp & Co's 13F filing for Q3 2019, filed 27 Nov 2019.